Omada Health, INC Form 4 insider transactions

Omada Health CEO Sean P. Duffy disposed of 4,413 shares of common stock to cover tax withholding obligations at a price of $24.28 per share.

Omada Health's President, Wei-Li Shao, disposed of 2,407 shares of common stock to cover tax withholding obligations at a price of $24.28 per share.

Omada Health, Inc. Director Jeryl L. Hilleman reported the acquisition of 376 restricted stock units (RSUs) on July 5, 2025, bringing her total direct beneficial ownership to 10,112 shares of Common Stock.

Omada Health, Inc. Director Jonathan D. Root was granted 237 restricted stock units as part of his compensation, increasing his direct beneficial ownership to 9,973 shares.

Omada Health, Inc. Director Trevor Fetter acquired 257 shares of common stock in the form of restricted stock units as part of the company's non-employee director compensation program.

Omada Health, Inc. director Julie D. Klapstein was granted 9,736 restricted stock units (RSUs) on June 5, 2025, which are set to fully vest on the first anniversary of the grant date.

Revelation Alpine, LLC and affiliated entities have converted over 4.1 million shares of Omada Health preferred stock into common stock, increasing their beneficial ownership to over 5.2 million common shares, in a transaction immediately preceding the company's initial public offering.

Multiple Revelation entities, significant shareholders in Omada Health, Inc., have converted their preferred stock holdings into common stock immediately prior to the company's initial public offering.

Jonathan D. Root, a Director at Omada Health, Inc., has reported substantial changes in his beneficial ownership of the company's common stock, including the conversion of millions of preferred shares into common stock immediately prior to the company's initial public offering and the grant of restricted stock units.

Omada Health Director Trevor Fetter has reported the acquisition of restricted stock units and the conversion of preferred stock into common shares, totaling a significant change in his beneficial ownership.

Omada Health, Inc. Director Anne Beal was granted 9,736 restricted stock units (RSUs) on June 5, 2025, which will fully vest on the first anniversary of the grant date.

Omada Health, Inc. Director Adam Stavisky was granted 9,736 restricted stock units (RSUs) on June 5, 2025, as part of his compensation.

Omada Health, Inc. disclosed that Director Sachin H. Jain was granted 9,736 restricted stock units (RSUs) on June 5, 2025, which will fully vest on the first anniversary of the grant date.

Omada Health, Inc. Director Jeryl L. Hilleman reported the acquisition of 9,736 restricted stock units (RSUs) on June 5, 2025, which are set to vest fully on the first anniversary of the grant date.

Omada Health, Inc. President Wei-Li Shao has reported the acquisition of 78,947 restricted stock units (RSUs) as part of executive compensation, vesting over four years.

Omada Health, Inc.'s Chief Financial Officer, Steven L. Cook, has been granted 65,789 restricted stock units (RSUs) as part of his compensation, aligning his interests with the company's long-term performance.

Omada Health, Inc. CEO and Director Sean P. Duffy has been granted 144,736 restricted stock units (RSUs) as part of his compensation, aligning his interests with long-term company performance.